WEST PHARMACEUTICAL SERVICES, INC. Proceeds from Long-term Lines of Credit
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Proceeds from Long-term Lines of Credit of $50.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLongTermLinesOfCredit · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from long-term lines of credit for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from long-term lines of credit for the quarter ending 2020-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from long-term lines of credit for the quarter ending 2020-06-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from long-term lines of credit for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from long-term lines of credit for fiscal 2021 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from long-term lines of credit for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from long-term lines of credit for fiscal 2019 was $108.50M.
- WEST PHARMACEUTICAL SERVICES, INC. proceeds from long-term lines of credit for fiscal 2018 was $0.00.
| Period end | Proceeds from Long-term Lines of Credit 3 month | Proceeds from Long-term Lines of Credit 3 month as first filed | Proceeds from Long-term Lines of Credit 6 month | Proceeds from Long-term Lines of Credit 6 month as first filed | Proceeds from Long-term Lines of Credit 9 month | Proceeds from Long-term Lines of Credit 9 month as first filed | Proceeds from Long-term Lines of Credit 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $50.00M 10-Q · filed 2026-07-23 | ||||||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-23 | ||||||
| 2021-12-31 | $0.00 10-K · filed 2022-02-22 | ||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $0.00 10-K · filed 2022-02-22 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $0.00 derived: sum of 2 quarters · filed 2020-10-23 | $0.00 10-Q · filed 2020-10-23 | $80.50M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $0.00 10-Q · filed 2020-07-24 | $80.50M derived: sum of 3 quarters · filed 2022-02-22 | $80.50M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $0.00 10-Q · filed 2020-04-24 | $80.50M derived: sum of 2 quarters · filed 2022-02-22 | $80.50M derived: sum of 3 quarters · filed 2022-02-22 | $80.50M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $80.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $80.50M derived: sum of 2 quarters · filed 2022-02-22 | $80.50M derived: sum of 3 quarters · filed 2022-02-22 | $108.50M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $0.00 derived: sum of 2 quarters · filed 2020-10-23 | $28.00M 10-Q · filed 2020-10-23 | $28.00M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $28.00M 10-Q · filed 2020-07-24 | $28.00M derived: sum of 3 quarters · filed 2021-02-23 | $28.00M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2019-03-31 | $28.00M 10-Q · filed 2020-04-24 | $28.00M derived: sum of 2 quarters · filed 2021-02-23 | $28.00M derived: sum of 3 quarters · filed 2021-02-23 | $28.00M derived: sum of 4 quarters · filed 2021-02-23 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | $0.00 derived: sum of 3 quarters · filed 2021-02-23 | $0.00 10-K · filed 2021-02-23 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $0.00 derived: sum of 2 quarters · filed 2019-10-29 | $0.00 10-Q · filed 2019-10-29 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $0.00 10-Q · filed 2019-07-29 | |||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | ||||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 | ||||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-05 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $0.00 derived: sum of 3 quarters · filed 2018-02-26 | $0.00 derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $0.00 derived: sum of 3 quarters · filed 2018-02-26 | $0.00 10-K · filed 2018-02-26 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $0.00 derived: sum of 2 quarters · filed 2016-10-31 | $0.00 10-Q · filed 2016-10-31 | $14.00M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $0.00 10-Q · filed 2016-08-01 | $14.00M derived: sum of 3 quarters · filed 2018-02-26 | $27.80M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-05 | $14.00M derived: sum of 2 quarters · filed 2018-02-26 | $27.80M derived: sum of 3 quarters · filed 2018-02-26 | $65.10M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $27.80M derived: sum of 2 quarters · filed 2018-02-26 | $65.10M derived: sum of 3 quarters · filed 2018-02-26 | $71.40M 10-K · filed 2018-02-26 | |||
| 2015-09-30 | $13.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $51.10M derived: sum of 2 quarters · filed 2016-10-31 | $57.40M 10-Q · filed 2016-10-31 | $98.40M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | $37.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $43.60M 10-Q · filed 2016-08-01 | $84.60M derived: sum of 3 quarters · filed 2017-02-28 | $124.10M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | $6.30M 10-Q · filed 2016-05-06 | $47.30M derived: sum of 2 quarters · filed 2017-02-28 | $86.80M derived: sum of 3 quarters · filed 2017-02-28 | $144.40M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $80.50M derived: sum of 2 quarters · filed 2017-02-28 | $138.10M derived: sum of 3 quarters · filed 2017-02-28 | $263.40M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $39.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $97.10M derived: sum of 2 quarters · filed 2015-11-02 | $222.40M 10-Q · filed 2015-11-02 | $265.30M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-06-30 | $57.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | $182.90M 10-Q · filed 2015-08-03 | $225.80M derived: sum of 3 quarters · filed 2016-02-26 | $297.30M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-03-31 | $125.30M 10-Q · filed 2015-05-06 | $168.20M derived: sum of 2 quarters · filed 2016-02-26 | $239.70M derived: sum of 3 quarters · filed 2016-02-26 | $299.00M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2013-12-31 | $42.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $114.40M derived: sum of 2 quarters · filed 2016-02-26 | $173.70M derived: sum of 3 quarters · filed 2016-02-26 | $292.70M 10-K · filed 2016-02-26 | |||
| 2013-09-30 | $71.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | $130.80M derived: sum of 2 quarters · filed 2014-11-03 | $249.80M 10-Q · filed 2014-11-03 | $343.30M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-06-30 | $59.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $178.30M 10-Q · filed 2014-08-01 | $6.70M 10-Q · filed 2013-08-05 | $271.80M derived: sum of 3 quarters · filed 2015-02-25 | $548.00M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $119.00M 10-Q · filed 2014-05-08 | $43.30M 10-Q · filed 2013-05-06 | $212.50M derived: sum of 2 quarters · filed 2015-02-25 | $488.70M derived: sum of 3 quarters · filed 2015-02-25 | $658.00M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2012-12-31 | $93.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $369.70M derived: sum of 2 quarters · filed 2015-02-25 | $539.00M derived: sum of 3 quarters · filed 2015-02-25 | $568.30M 10-K · filed 2015-02-25 | |||
| 2012-09-30 | $276.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $445.50M derived: sum of 2 quarters · filed 2013-11-04 | $474.80M 10-Q · filed 2013-11-04 | $93.00M 10-Q · filed 2012-11-05 | $651.70M derived: sum of 4 quarters · filed 2014-02-27 | ||
| 2012-06-30 | $169.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | $198.60M 10-Q · filed 2013-08-05 | $375.50M derived: sum of 3 quarters · filed 2014-02-27 | $386.00M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-03-31 | $29.30M 10-Q · filed 2013-05-06 | $206.20M derived: sum of 2 quarters · filed 2014-02-27 | $216.70M derived: sum of 3 quarters · filed 2014-02-27 | $216.70M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2011-12-31 | $176.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $187.40M derived: sum of 2 quarters · filed 2014-02-27 | $187.40M derived: sum of 3 quarters · filed 2014-02-27 | $193.40M 10-K · filed 2014-02-27 | |||
| 2011-09-30 | $10.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $10.50M derived: sum of 2 quarters · filed 2012-11-05 | $16.50M 10-Q · filed 2012-11-05 | ||||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $6.00M 10-Q · filed 2012-08-06 | |||||
| 2011-03-31 | $6.00M 10-Q · filed 2012-05-04 | ||||||
| 2010-12-31 | $26.60M 10-K · filed 2013-02-27 | ||||||
| 2009-12-31 | $16.40M 10-K/A · filed 2012-03-01 | ||||||
| 2008-12-31 | $9.50M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |